SIAS
JAZZ icon

Shine Investment Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Shine Investment Advisory Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$5K Hold
36
– – ﹤0.01% 632
2020
Q2 		$4K Hold
36
– – ﹤0.01% 663
2020
Q1 		$4K Hold
36
– – ﹤0.01% 633
2019
Q4 		$5K Hold
36
– – ﹤0.01% 663
2019
Q3 		$5K Hold
36
– – ﹤0.01% 655
2019
Q2 		$5K Hold
36
– – ﹤0.01% 619
2019
Q1 		$5K Buy
36
+16
+80% +$2.09K ﹤0.01% 626
2018
Q4 		$2K Buy
+20
New +$2.97K ﹤0.01% 656

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Shine Investment Advisory Services's JAZZ Position: Q3 2020 in Review

Shine Investment Advisory Services held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2020 at 36 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Shine Investment Advisory Services first reported a position in JAZZ in Q4 2018 and has held it in 8 quarters since. 390 funds tracked by Wall St. Rank hold JAZZ as of Q3 2020.

  • Shine Investment Advisory Services held 36 shares of Jazz Pharmaceuticals worth $5K as of Q3 2020.
  • Shine Investment Advisory Services left its Jazz Pharmaceuticals share count unchanged in Q3 2020.
  • Jazz Pharmaceuticals made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #632 holding.
  • Shine Investment Advisory Services first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 8 quarters since.
  • 390 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.